FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025207630> ?p ?o ?g. }

• W2025207630 endingPage "17133" @default.
• W2025207630 startingPage "17122" @default.
• W2025207630 abstract "Cystic fibrosis transmembrane conductance regulator (CFTR) is the only ligand-gated ion channel that hydrolyzes its agonist, ATP. CFTR gating has been argued to be tightly coupled to its enzymatic activity, but channels do open occasionally in the absence of ATP and are reversibly activated (albeit weakly) by nonhydrolyzable nucleotides. Why the latter only weakly activates CFTR is not understood. Here we show that CFTR activation by adenosine 5'-O-(thiotriphosphate) (ATPγS), adenosine 5'-(β,γ-imino)triphosphate (AMP-PNP), and guanosine 5'-3-O-(thio)triphosphate (GTPγS) is enhanced substantially by gain of function (GOF) mutations in the cytosolic loops that increase unliganded activity. This enhancement correlated with the base-line nucleotide-independent activity for several GOF mutations. AMP-PNP or ATPγS activation required both nucleotide binding domains (NBDs) and was disrupted by a cystic fibrosis mutation in NBD1 (G551D). GOF mutant channels deactivated very slowly upon AMP-PNP or ATPγS removal (τdeac ∼ 100 s) implying tight binding between the two NBDs. Despite this apparently tight binding, neither AMP-PNP nor ATPγS activated even the strongest GOF mutant as strongly as ATP. ATPγS-activated wild type channels deactivated more rapidly, indicating that GOF mutations in the cytosolic loops reciprocally/allosterically affect nucleotide occupancy of the NBDs. A GOF mutation substantially rescued defective ATP-dependent gating of G1349D-CFTR, a cystic fibrosis NBD2 signature sequence mutant. Interestingly, the G1349D mutation strongly disrupted activation by AMP-PNP but not by ATPγS, indicating that these analogs interact differently with the NBDs. We conclude that poorly hydrolyzable nucleotides are less effective than ATP at opening CFTR channels even when they bind tightly to the NBDs but are converted to stronger agonists by GOF mutations." @default.
• W2025207630 created "2016-06-24" @default.
• W2025207630 creator A5021120908 @default.
• W2025207630 creator A5042841382 @default.
• W2025207630 creator A5046597133 @default.
• W2025207630 creator A5049576480 @default.
• W2025207630 date "2013-06-01" @default.
• W2025207630 modified "2023-09-26" @default.
• W2025207630 title "Converting Nonhydrolyzable Nucleotides to Strong Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Agonists by Gain of Function (GOF) Mutations" @default.
• W2025207630 cites W1524370537 @default.
• W2025207630 cites W1590184168 @default.
• W2025207630 cites W1963790115 @default.
• W2025207630 cites W1971736406 @default.
• W2025207630 cites W1973876121 @default.
• W2025207630 cites W1977353319 @default.
• W2025207630 cites W1991977085 @default.
• W2025207630 cites W1992278768 @default.
• W2025207630 cites W1995579048 @default.
• W2025207630 cites W1998093640 @default.
• W2025207630 cites W2004844038 @default.
• W2025207630 cites W2010691166 @default.
• W2025207630 cites W2019143250 @default.
• W2025207630 cites W2032788621 @default.
• W2025207630 cites W2035478373 @default.
• W2025207630 cites W2036917849 @default.
• W2025207630 cites W2040690917 @default.
• W2025207630 cites W2043524902 @default.
• W2025207630 cites W2047930213 @default.
• W2025207630 cites W2050912869 @default.
• W2025207630 cites W2051221113 @default.
• W2025207630 cites W2058371000 @default.
• W2025207630 cites W2059043844 @default.
• W2025207630 cites W2062950568 @default.
• W2025207630 cites W2067463439 @default.
• W2025207630 cites W2081959026 @default.
• W2025207630 cites W2084896237 @default.
• W2025207630 cites W2089817117 @default.
• W2025207630 cites W2091060891 @default.
• W2025207630 cites W2091908548 @default.
• W2025207630 cites W2092594813 @default.
• W2025207630 cites W2098281388 @default.
• W2025207630 cites W2106960190 @default.
• W2025207630 cites W2111453829 @default.
• W2025207630 cites W2111935912 @default.
• W2025207630 cites W2114087686 @default.
• W2025207630 cites W2122843005 @default.
• W2025207630 cites W2124233675 @default.
• W2025207630 cites W2148598721 @default.
• W2025207630 cites W2152289994 @default.
• W2025207630 cites W2161849629 @default.
• W2025207630 cites W2167284177 @default.
• W2025207630 cites W2170963483 @default.
• W2025207630 cites W239028284 @default.
• W2025207630 doi "https://doi.org/10.1074/jbc.m112.442582" @default.
• W2025207630 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3682518" @default.
• W2025207630 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23620589" @default.
• W2025207630 hasPublicationYear "2013" @default.
• W2025207630 type Work @default.
• W2025207630 sameAs 2025207630 @default.
• W2025207630 citedByCount "6" @default.
• W2025207630 countsByYear W20252076302014 @default.
• W2025207630 countsByYear W20252076302015 @default.
• W2025207630 countsByYear W20252076302016 @default.
• W2025207630 countsByYear W20252076302019 @default.
• W2025207630 crossrefType "journal-article" @default.
• W2025207630 hasAuthorship W2025207630A5021120908 @default.
• W2025207630 hasAuthorship W2025207630A5042841382 @default.
• W2025207630 hasAuthorship W2025207630A5046597133 @default.
• W2025207630 hasAuthorship W2025207630A5049576480 @default.
• W2025207630 hasBestOaLocation W20252076301 @default.
• W2025207630 hasConcept C104317684 @default.
• W2025207630 hasConcept C113027372 @default.
• W2025207630 hasConcept C118716 @default.
• W2025207630 hasConcept C12554922 @default.
• W2025207630 hasConcept C141315368 @default.
• W2025207630 hasConcept C143065580 @default.
• W2025207630 hasConcept C181199279 @default.
• W2025207630 hasConcept C185592680 @default.
• W2025207630 hasConcept C194544171 @default.
• W2025207630 hasConcept C23265538 @default.
• W2025207630 hasConcept C2778428886 @default.
• W2025207630 hasConcept C2779564974 @default.
• W2025207630 hasConcept C501734568 @default.
• W2025207630 hasConcept C512185932 @default.
• W2025207630 hasConcept C55493867 @default.
• W2025207630 hasConcept C75578959 @default.
• W2025207630 hasConcept C86803240 @default.
• W2025207630 hasConcept C95444343 @default.
• W2025207630 hasConceptScore W2025207630C104317684 @default.
• W2025207630 hasConceptScore W2025207630C113027372 @default.
• W2025207630 hasConceptScore W2025207630C118716 @default.
• W2025207630 hasConceptScore W2025207630C12554922 @default.
• W2025207630 hasConceptScore W2025207630C141315368 @default.
• W2025207630 hasConceptScore W2025207630C143065580 @default.
• W2025207630 hasConceptScore W2025207630C181199279 @default.
• W2025207630 hasConceptScore W2025207630C185592680 @default.
• W2025207630 hasConceptScore W2025207630C194544171 @default.
• W2025207630 hasConceptScore W2025207630C23265538 @default.

• next